You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (80) |
Back to Search
EPIGENETIC THERAPY AUGMENTS DOCETAXEL IN THE TREATMENT OF BREAST CANCER: AN IN VITRO AND IN VIVO EVALUATION
- In: Poster Session
- At: Düsseldorf (Germany) (2015)
- Type: Poster
- By: JAIN, Prateek (MCOPS, Manipal University, Manipal, India)
- Co-author(s): Prateek Jain
- Abstract:
Docetaxel (DTX) is one of the most effective chemotherapeutic agents in the treatment of breast cancer. Unfortunately, there is altered response to DTX due to resistance. DNA methylation, an epigenetic event, plays a vital role in cancer and chemotherapy drug resistance. Exploiting the gene reactivation by using epigenetically acting agents in
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026